Novavax blames weak demand for Covid jab as it slashes revenue forecast

US drugmaker’s shares sink over 30% in sign of challenges facing companies making late entry to vaccine market

Pfizer tests vaccine to fend off spread of tick-borne Lyme disease

US drugmaker and French partner begin late-stage trial with 14% of global population showing evidence of infection

Cold and hungry: Food inflation bites Canada's north

By Rod Nickel IQALUIT, Nunavut - In Canada's remote north, residents have long paid dearly for food, and rising prices have worsened an already dire situation, exposing the vulnerability of one...

BioNTech SE Slides on Vaccine Revenue Miss But Consensus Was 'Too High'

By Sam Boughedda BioNTech SE shares tumbled more than 9% Monday after reporting second-quarter earnings before the open. The drugmaker posted second-quarter earnings of €6.45 per share on revenue...

Boeing Expected to Resume 787 Dreamliner Deliveries in the Coming Days

By Sam Boughedda The Federal Aviation Administration revealed on Monday that Boeing will restart deliveries of its 787 Dreamliners in the coming days. The regulator said in a statement that they...

Viatris, First Solar rise; Tyson Foods, Nvidia fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday: Viatris Inc., up 36 cents to $10.09.The generic drugmaker beat Wall Street's second-quarter earnings and revenue...

Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics

Pfizer says it will pay $68.50 a share in cash for Global Blood Therapeutics. The Wall Street Journal reported Friday that the companies were in advanced talks. The company has one of the few...

Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics

Pfizer has agreed to buy Global Blood Therapeutics for $5.4 billion, a deal that will give the big drugmaker a foothold in the treatment of sickle-cell disease.

Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics

Pfizer has agreed to buy Global Blood Therapeutics for $5.4 billion, a deal that will give the big drugmaker a foothold in the treatment of sickle-cell disease.

Pfizer reaches $5.4B deal for Global Blood Therapeutics

Pfizer Inc. has agreed to buy Global Blood Therapeutics Inc. for $5.4 billion, according to people familiar with the matter, in a deal that would give the big drugmaker a foothold in the treatment...

2 Reasons This Beaten-Down Stock Could Be About to Rebound

This drugmaker has more than one trick up its sleeve.

Merck defends tax approach against senator’s claims of avoidance

Chief financial officer says drugmaker complies with law amid congressional probe

Eli Lilly says Indiana's abortion law will lead the drugmaker to grow in other states

Indiana's Legislature on Friday became the first in the nation to pass new legislation restricting access to abortions. Cummins, which employs about 10,000 people in Indiana, spoke out over the...

Quest to Cut Prescription Drug Prices Puts Insulin in Spotlight

By Liz Moyer Investing.com -- Lawmakers are once again trying to get caps on prescription drug pricing across the finish line, and that puts insulin in the spotlight. The market for insulin is...

Hyzon Motors Tumbles After Announcing Investigation into China Operations

By Sam Boughedda Hyzon Motors Inc shares plunged over 40% Friday following a filing by the company aftermarket Thursday that revealed the company's Board of Directors hired an independent outside...

Ukraine buries agricultural 'titan' killed in missile strike

KYIV - Orthodox chants of mourning resounded in a packed central Kyiv cathedral on Friday as Ukraine buried an agricultural tycoon with his wife after they were killed in a missile strike that...

Big U.S. chicken company, Mountaire, asks contractors to oppose transparency rule

By Leah Douglas WASHINGTON - Mountaire Farms, a top U.S. chicken company, is pressuring its contract farmers to oppose a Biden administration proposal aimed at improving their conditions because...

Pfizer in Talks to Buy Global Blood Therapeutics for $5 Billion, Report Says

Pfizer is in late-stage negotiations to buy the drug maker Global Blood Therapeutics for $5 billion. Other companies are also continuing to make bids, The Wall Street Journal reported Friday....

Deutsche Bank ex-trader's conviction thrown out in U.S. Libor-rigging case

By Jonathan Stempel NEW YORK - A U.S. judge on Friday threw out a former Deutsche Bank AG (NYSE:DB) trader's conviction for conspiring to manipulate the global lending benchmark Libor, after an...

Pfizer in Global Blood Therapeutics Takeover Talks

By Sam Boughedda Pfizer is reportedly in talks to acquire Global Blood Therapeutics Inc (NASDAQ:GBT), according to a report by The Wall Street Journal Friday. The news follows Thursday's report...

Pfizer in advanced talks to buy Global Blood Therapeutics for $5 billion

- Pfizer Inc (NYSE:PFE) is in advanced talks to buy drugmaker Global Blood Therapeutics (NASDAQ:GBT) for about $5 billion, the Wall Street Journal reported on Friday, citing people familiar with...

Pfizer in advanced talks to buy Global Blood Therapeutics for $5 billion

Pfizer Inc is in advanced talks to buy drugmaker Global Blood Therapeutics for about $5 billion, the Wall Street Journal reported on Friday, citing people familiar with the matter.

UPDATE: Eli Lilly & Co. Shares Slide After Missing Estimates

Eli Lilly & Co. shares are down Thursday following its second-quarter earnings report, which saw it miss analyst estimates. The drugmaker reported earnings of $1.25 per share, $0.46 below the...

Cummins workers to get $2,785 cost-of-living payment

LONDON - Britain's Unite trade union has negotiated a 2,300 pounds ($2,785.30) cost-of-living payment that will cover 2,730 workers at U.S. truck engine maker Cummins (NYSE:CMI), the union said...

Apollo-led group to take Atlas Air private for $3 billion

-Air-freight company Atlas Air (NASDAQ:AAWW) Worldwide Holdings Inc is being taken private for nearly $3 billion by an investor group led by private equity giant Apollo Global Management...

Coinbase, BlackRock ink crypto trading partnership targeting institutional clients

- Cryptocurrency exchange Coinbase (NASDAQ:COIN) Global Inc said on Thursday it has partnered with BlackRock (NYSE:BLK), the world's largest asset manager, to provide institutional clients with...

Amgen Acquires Drugmaker ChemoCentryx for $3.7 Billion

Amgen is buying ChemoCentryx for roughly $3.7 billion, including debt. The all-cash deal works out at $52-a share and is a 115% premium to the company's last closing price. The drugmaker is...

Eli Lilly cuts annual profit view as lower insulin prices hit Q2 sales

Eli Lilly and Co on Thursday cut its full-year profit forecast for the second time after quarterly results missed estimates due to lower prices of insulin and competition for its cancer drug,...

Eli Lilly's Covid-19 Antibody Treatment to Be Sold Commercially

Biden administration, drug maker in talks to ensure bebtelovimab remains available to people without health insurance.

Here's what to keep in mind ahead of Eli Lilly's earnings Thursday

Eli Lilly is a global health care leader that creates in-demand, high-quality treatments for the world's most critical health challenges. The company will be reporting its second quarter financial...

One-Stop Business News, backed by Mark Cuban. Free to Use →